Form 4: SOPHiA GENETICS SA Executive Sells Shares
Insider Transaction (Form 4)
Jurgi Camblong, Executive Chairman and a Director of SOPHiA GENETICS SA, sold 44,381 shares of common stock on July 20, 2026.
Summary
- Open-market sale: disposed of 19,800 Ordinary Shares at $6.32 ($125,201) on July 20, 2026; holds 3,512,822 after (Direct).
- Option exercise/conversion: acquired 4,581 Ordinary Shares at $3.16 ($14,476) on July 20, 2026; holds 3,517,403 after (Direct).
- Open-market sale: disposed of 4,581 Ordinary Shares at $6.17 ($28,244) on July 20, 2026; holds 3,512,822 after (Direct).
- Open-market sale: disposed of 20,000 Ordinary Shares at $6.63 ($132,654) on July 21, 2026; holds 3,492,822 after (Direct).
- Option exercise/conversion: disposed of 4,581 Share Option (Right to Buy) on July 20, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $286,099 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jurgi Camblong — Director, Officer (Executive Chairman)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-20 | Open-market sale | Ordinary Shares | 19,800 | $6 | $125.2K | 3,512,822 |
| 2026-07-20 | Option exercise/conversion | Ordinary Shares | 4,581 | $3 | $14.5K | 3,517,403 |
| 2026-07-20 | Open-market sale | Ordinary Shares | 4,581 | $6 | $28.2K | 3,512,822 |
| 2026-07-21 | Open-market sale | Ordinary Shares | 20,000 | $7 | $132.7K | 3,492,822 |
| 2026-07-20 | Option exercise/conversion | Share Option (Right to Buy) | 4,581 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-20 | Open-market sale (19,800 shares) |
| 2026-07-20 | Option exercise/conversion (4,581 shares) |
| 2026-07-20 | Open-market sale (4,581 shares) |
| 2026-07-21 | Open-market sale (20,000 shares) |
| 2026-07-20 | Option exercise/conversion (4,581 shares) |
Keywords
insider transaction, Form 4, SOPH, SOPHiA GENETICS SA, bearish, Jurgi Camblong
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.